<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:03:07Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5111011" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5111011</identifier><datestamp>2016-11-29</datestamp><setSpec>cshmolcase</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cold Spring Harb Mol Case Stud</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cold Spring Harb Mol Case Stud</journal-id>
      <journal-id journal-id-type="hwp">cshmcs</journal-id>
      <journal-id journal-id-type="pmc">cshmcs</journal-id>
      <journal-id journal-id-type="publisher-id">cshmcs</journal-id>
      <journal-title-group>
        <journal-title>Cold Spring Harbor Molecular Case Studies</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2373-2873</issn>
      <publisher>
        <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5111011</article-id>
      <article-id pub-id-type="pmcid">PMC5111011</article-id>
      <article-id pub-id-type="pmc-uid">5111011</article-id>
      <article-id pub-id-type="pmid">27900362</article-id>
      <article-id pub-id-type="doi">10.1101/mcs.a001172</article-id>
      <article-id pub-id-type="publisher-id">WebsterMCS001172</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>De novo <italic>PHIP</italic>-predicted deleterious variants are associated with developmental delay, intellectual disability, obesity, and dysmorphic features</article-title>
        <alt-title alt-title-type="left-running">PHIP <italic>variants cause developmental delay and obesity</italic></alt-title>
        <alt-title alt-title-type="right-running">PHIP <italic>variants cause developmental delay and obesity</italic></alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Webster</surname>
            <given-names>Emily</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Megan T.</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alexander</surname>
            <given-names>Nora</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Desai</surname>
            <given-names>Sonal</given-names>
          </name>
          <xref ref-type="aff" rid="af3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Naidu</surname>
            <given-names>Sakkubai</given-names>
          </name>
          <xref ref-type="aff" rid="af3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bekheirnia</surname>
            <given-names>Mir Reza</given-names>
          </name>
          <xref ref-type="aff" rid="af4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lewis</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="af4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Retterer</surname>
            <given-names>Kyle</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Juusola</surname>
            <given-names>Jane</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Wendy K.</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
          <xref ref-type="aff" rid="af5">5</xref>
        </contrib>
      </contrib-group>
      <aff id="af1"><label>1</label>Department of Pediatrics, Columbia University Medical Center, New York, New York 10032, USA;</aff>
      <aff id="af2"><label>2</label>GeneDx, Gaithersburg, Maryland 20877, USA;</aff>
      <aff id="af3"><label>3</label>Kennedy Krieger Institute, Baltimore, Maryland 21205, USA;</aff>
      <aff id="af4"><label>4</label>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA;</aff>
      <aff id="af5"><label>5</label>Department of Medicine, Columbia University Medical Center, New York, New York 10032, USA</aff>
      <author-notes>
        <corresp>Corresponding author: <email>wkc15@columbia.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2016</year>
      </pub-date>
      <volume>2</volume>
      <issue>6</issue>
      <elocation-id>a001172</elocation-id>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>
          <ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.cshlp.org/site/misc/terms.xhtml">Â© 2016 Webster et al.; Published by Cold Spring Harbor Laboratory Press</ext-link>
        </copyright-statement>
        <copyright-year>2016</copyright-year>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted reuse and redistribution provided that the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="WebsterMCS001172.pdf"/>
      <abstract>
        <p>Using whole-exome sequencing, we have identified novel de novo heterozygous pleckstrin homology domain-interacting protein (<italic>PHIP</italic>) variants that are predicted to be deleterious, including a frameshift deletion, in two unrelated patients with common clinical features of developmental delay, intellectual disability, anxiety, hypotonia, poor balance, obesity, and dysmorphic features. A nonsense mutation in <italic>PHIP</italic> has previously been associated with similar clinical features. Patients with microdeletions of 6q14.1, including <italic>PHIP</italic>, have a similar phenotype of developmental delay, intellectual disability, hypotonia, and obesity, suggesting that the phenotype of our patients is a result of loss-of-function mutations. <italic>PHIP</italic> produces multiple protein products, such as PHIP1 (also known as DCAF14), PHIP, and NDRP. PHIP1 is one of the multiple substrate receptors of the proteolytic CUL4-DDB1 ubiquitin ligase complex. CUL4B deficiency has been associated with intellectual disability, central obesity, muscle wasting, and dysmorphic features. The overlapping phenotype associated with CUL4B deficiency suggests that <italic>PHIP</italic> mutations cause disease through disruption of the ubiquitin ligase pathway.</p>
      </abstract>
      <kwd-group>
        <kwd>abdominal obesity</kwd>
        <kwd>central hypotonia</kwd>
        <kwd>intellectual disability, mild</kwd>
        <kwd>mild global developmental delay</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="funding-1">
          <funding-source>Simons Foundation <named-content content-type="funder-id">http://dx.doi.org/10.13039/100000893</named-content></funding-source>
        </award-group>
        <award-group id="funding-2">
          <funding-source>National Institute of Diabetes and Digestive and Kidney Diseases <named-content content-type="funder-id">http://dx.doi.org/10.13039/100000062</named-content></funding-source>
          <award-id>T35DK093430</award-id>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="8"/>
      </counts>
    </article-meta>
  </front>
  <body><sec sec-type="introduction" id="s1"><title>INTRODUCTION</title><p>Pleckstrin homology domain-interacting protein (<italic>PHIP</italic>; ENSG00000146247), located on Chromosome 6q14.1, was identified as a candidate gene for severe intellectual disability in one child in a study of 100 children with intelligence quotients (IQs) below 50 and their unaffected parents (<xref rid="WEBSTERMCS001172C4" ref-type="bibr">de Ligt et al. 2012</xref>). <italic>PHIP</italic> produces at least three proteins (PHIP1, PHIP, and NDRP) through alternative splicing. PHIP1 (also known as DCAF14) acts as a substrate receptor in a ubiquitin ligase pathway and mediates substrate-specific proteolysis (<xref rid="WEBSTERMCS001172C15" ref-type="bibr">Lee and Zhou 2007</xref>). Mutations affecting ubiquitin ligase pathways have been associated with a number of diseases, including neurological disorders, autoimmune disorders, and cancers (<xref rid="WEBSTERMCS001172C1" ref-type="bibr">Ardley and Robinson 2004</xref>; <xref rid="WEBSTERMCS001172C19" ref-type="bibr">Matentzoglu and Scheffner 2008</xref>; <xref rid="WEBSTERMCS001172C18" ref-type="bibr">Lohr et al. 2010</xref>; <xref rid="WEBSTERMCS001172C17" ref-type="bibr">Lipkowitz and Weissman 2011</xref>). Using whole-exome sequencing (WES), we identified two novel de novo heterozygous predicted deleterious <italic>PHIP</italic> variants in two unrelated patients with a common phenotype of developmental delay, intellectual disability, anxiety, hypotonia, poor balance, obesity, and dysmorphic features.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2a"><title>Genomic Analysis</title><p>A total of 2522 patients referred to a single clinical genetic diagnostic lab (GeneDx) with developmental delay or intellectual disability were analyzed by WES. Two patients were identified with novel de novo variants in <italic>PHIP</italic>. WES of the two patients identified a de novo variant in the <italic>PHIP</italic> gene produced an average of 9.3 GB of sequence per sample. The mean coverage of captured regions was â¼120Ã per sample, with â¼98% covered with at least 10Ã coverage, an average of 92% of base call quality of Q30 or greater and an overall average mean quality score of Q36 (Supplemental Table S1).</p><p>The variants found in <italic>PHIP</italic> include a frameshift deletion, NM_017934.5:p.L260Wfs*48, and a missense variant, NM_017934.5:p.F17S, located in an Î±-helix (<xref ref-type="table" rid="WEBSTERMCS001172TB1">Table 1</xref>). Neither of the variants has been observed in ExAC (Exome Aggregation Consortium; <uri xlink:href="http://exac.broadinstitute.org">http://exac.broadinstitute.org</uri>, accessed in September 2015). Predictions of pathogenicity for p.F17S were variable, but the variant was predicted to be pathogenic by SIFT (Sorting Intolerant from Tolerant; <xref rid="WEBSTERMCS001172C14" ref-type="bibr">Kumar et al. 2009</xref>), PROVEAN (Protein Variation Effect Analyzer; <xref rid="WEBSTERMCS001172C3" ref-type="bibr">Choi and Chan 2015</xref>), MutationTaster (<xref rid="WEBSTERMCS001172C21" ref-type="bibr">Schwarz et al. 2014</xref>), and CADD (Combined Annotation-Dependent Depletion; <xref rid="WEBSTERMCS001172C13" ref-type="bibr">Kircher et al. 2014</xref>). Cross-species comparison suggests that the phenylalanine at position 17 is highly conserved. <italic>PHIP</italic> has a high haploinsufficiency score [<italic>p</italic>(HI) = 0.95] (<xref rid="WEBSTERMCS001172C10" ref-type="bibr">Huang et al. 2010</xref>), as well as intolerance to both loss-of-function variants [(<italic>p</italic>(LI) = 1.00] and missense variants (<italic>z</italic>-score = 5.20) (<xref rid="WEBSTERMCS001172C5" ref-type="bibr">Exome Aggregation Consortium et al. 2015</xref>).</p><table-wrap id="WEBSTERMCS001172TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Variant table</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene</th><th align="center" rowspan="1" colspan="1">Chromosome</th><th align="center" rowspan="1" colspan="1">NCBI reference sequence</th><th align="center" rowspan="1" colspan="1">HGVS DNA reference</th><th align="center" rowspan="1" colspan="1">HGVS protein reference</th><th align="center" rowspan="1" colspan="1">Variant type</th><th align="center" rowspan="1" colspan="1">Predicted effect</th><th align="center" rowspan="1" colspan="1">dbSNP/dbVar ID</th><th align="center" rowspan="1" colspan="1">Genotype</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic>PHIP</italic></td><td rowspan="1" colspan="1">6q14.1</td><td rowspan="1" colspan="1">NM_017934.5</td><td rowspan="1" colspan="1">c.50T&gt;C</td><td rowspan="1" colspan="1">p.F17S</td><td rowspan="1" colspan="1">Missense</td><td rowspan="1" colspan="1">Loss of function</td><td rowspan="1" colspan="1">None</td><td rowspan="1" colspan="1">Heterozygous</td></tr><tr><td rowspan="1" colspan="1"><italic>PHIP</italic></td><td rowspan="1" colspan="1">6q14.1</td><td rowspan="1" colspan="1">NM_017934.5</td><td rowspan="1" colspan="1">c.779delT</td><td rowspan="1" colspan="1">p.L260Wfs*48</td><td rowspan="1" colspan="1">Frameshift deletion</td><td rowspan="1" colspan="1">Loss of function</td><td rowspan="1" colspan="1">None</td><td rowspan="1" colspan="1">Heterozygous</td></tr></tbody></table><table-wrap-foot><fn><p>NCBI, National Center for Biotechnology Information; HGVS, Human Genome Variation Society; dbSNP, Database for Short Genetic Variations; dbVar, Database of Genomic Structural Variation.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2b"><title>Clinical Presentation</title><p>Both patients with predicted deleterious de novo <italic>PHIP</italic> variants are females, ages 14 (Patient 1) and 8 (Patient 2), and have common features of global developmental delay, intellectual disability, anxiety, hypotonia, poor balance, obesity, and dysmorphic facial features (<xref ref-type="table" rid="WEBSTERMCS001172TB2">Table 2</xref>; <xref ref-type="fig" rid="WEBSTERMCS001172F1">Fig. 1</xref>). Both patients had normal weight at birth, but are now at or above the 97th percentile for weight and body mass index (BMI). Brain malformations are not associated with either patient.</p><fig id="WEBSTERMCS001172F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Facial dysmorphisms of Patient 1 showing a small, upturned nose and deep-set eyes.</p></caption><graphic xlink:href="WebsterMCS001172_F1"/></fig><table-wrap id="WEBSTERMCS001172TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Clinical features of individuals with predicted deleterious variants in <italic>PHIP</italic></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><tbody><tr><td rowspan="1" colspan="1">Patient no.</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">de Ligt et al. (Trio 5)</td></tr><tr><td rowspan="1" colspan="1">Current age (yr)</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">UNK</td></tr><tr><td rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">Female</td></tr><tr><td rowspan="1" colspan="1">Variant</td><td rowspan="1" colspan="1">c.50T&gt;C:p.F17S</td><td rowspan="1" colspan="1">c.779delT:p.L260Wfs*48</td><td rowspan="1" colspan="1">c.3447T&gt;G:p.Y1149*</td></tr><tr><td rowspan="1" colspan="1">Prenatal issues</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">Meconium stained amniotic fluid</td></tr><tr><td rowspan="1" colspan="1">Neonatal issues</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">Feeding problems</td></tr><tr><td rowspan="1" colspan="1">Congenital anomalies</td><td rowspan="1" colspan="1">Hip dysplasia</td><td rowspan="1" colspan="1">Laryngeal cleft</td><td rowspan="1" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">Dysmorphic features</td><td rowspan="1" colspan="1">Fleshy ears, full chin, micrognathia</td><td rowspan="1" colspan="1">Fleshy earlobes, small nose, deep-set eyes, up-turned upper lip, short and smooth philtrum, round face</td><td rowspan="1" colspan="1">Straight eyebrows, blepharophimosis, mild ptosis, long philtrum, full lips, tapered fingers, clinodactyly of the fifth finger, long toes</td></tr><tr><td rowspan="1" colspan="1">Birth weight</td><td rowspan="1" colspan="1">WT = 3.40 kg (64%)</td><td rowspan="1" colspan="1">WT = 3.35 kg (60%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Current BMI, HT, WT, OFC</td><td rowspan="1" colspan="1">At 12 yr 10 mo:<break/>BMI = 29.9 kg/m<sup>2</sup> (z-score = 2.06)<break/>WT = 81.5 kg (99%)<break/>HT = 165 cm (89%)<break/>OFC = 57 cm (&gt;97%)</td><td rowspan="1" colspan="1">At 8 yr 2 mo:<break/>BMI = 23.6 kg/m<sup>2</sup> (z-score = 2.08)<break/>WT = 39.8 kg (97%)<break/>HT = 129.9 cm (59%)<break/>OFC = 49.1 cm (4%)</td><td rowspan="1" colspan="1">At UNK age: BMI = 25.4 kg/m<sup>2</sup><break/>WT = 56.8 kg (&gt;+2 SD)<break/>HT = 149.5 cm (+0.5 SD)<break/>OFC = 57.6 cm (&gt;+2.5 SD)</td></tr><tr><td rowspan="1" colspan="1">Obesity</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">Y</td></tr><tr><td rowspan="1" colspan="1">Insulin resistance</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Developmental delay</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">Y</td></tr><tr><td rowspan="1" colspan="1">Age at sitting</td><td rowspan="1" colspan="1">9 mo</td><td rowspan="1" colspan="1">6 mo</td><td rowspan="1" colspan="1">12 mo</td></tr><tr><td rowspan="1" colspan="1">Age at walking</td><td rowspan="1" colspan="1">18 mo</td><td rowspan="1" colspan="1">14 mo</td><td rowspan="1" colspan="1">24 mo</td></tr><tr><td rowspan="1" colspan="1">Age at talking</td><td rowspan="1" colspan="1">18 mo</td><td rowspan="1" colspan="1">First words at 16 mo, words together by 3 yr, sentences at 4 yr, could not be understood by most people until age 5</td><td rowspan="1" colspan="1">First word at 5 yr</td></tr><tr><td rowspan="1" colspan="1">Intellectual disabilities</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">Y</td></tr><tr><td rowspan="1" colspan="1">Full-scale IQ</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">UNK</td><td rowspan="1" colspan="1">&lt;50</td></tr><tr><td rowspan="1" colspan="1">Current speech abilities</td><td rowspan="1" colspan="1">Speaks in full sentences</td><td rowspan="1" colspan="1">Nasal speech</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">ADD</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Brain MRI/CT results</td><td rowspan="1" colspan="1">Unremarkable</td><td rowspan="1" colspan="1">Unremarkable</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Behavioral issues</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">Y, aggressive toward siblings</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Regression</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Hypotonia</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1">Y</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Balance/coordination</td><td rowspan="1" colspan="1">Poor</td><td rowspan="1" colspan="1">Poor</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Orthopedic issues</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Gastrointestinal</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">Diarrhea, constipation</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Ophthalmologic issues</td><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">Strabismus</td><td rowspan="1" colspan="1">Strabismus</td></tr><tr><td rowspan="1" colspan="1">Self-care abilities (e.g., dressing, feeding)</td><td rowspan="1" colspan="1">Began dressing herself at 9 yr, has trouble with buttons/shoes</td><td rowspan="1" colspan="1">Can dress, feed, and help herself but hates utensils, prefers her hands, is sloppy with brushing her hair</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Other significant medical problems</td><td rowspan="1" colspan="1">Polycystic ovarian disease, menstrual irregularities</td><td rowspan="1" colspan="1">Headaches, sleep problems</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Additional genetic variants</td><td rowspan="1" colspan="1">5q23.2 duplication, inherited</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Other notes:</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Translucent skin on chest/abdomen</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Y, yes; N, no; UNK, unknown; mo, months; yr, years; BMI, body mass index; HT, height; WT, weight; OFC, occipital frontal circumference; %, percentile; ADD, attention-deficit disorder; SD, standard deviations.</p></fn></table-wrap-foot></table-wrap><p>Patient 1 has an IQ of 60, which dropped from a previous IQ of 83. In addition to obesity, Patient 1 has insulin resistance and polycystic ovarian syndrome diagnosed by an endocrinologist and treated with metformin. She has dysmorphic features including fleshy ears, full chin, and micrognathia. Before WES, a chromosome microarray was performed that revealed a 95-kb paternally inherited 5q23.2 duplication, including <italic>CEP120M</italic> and <italic>CSNK1G3</italic> genes.</p><p>Patient 2 has behavioral issues and is aggressive to her siblings. She also has a number of dysmorphic facial features, including fleshy earlobes, small nose, deep-set eyes, up-turned upper lip, short philtrum, and round face, and had a laryngeal cleft at birth. A chromosome microarray was normal.</p></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>Using clinical WES, we have identified two unrelated patients with novel de novo heterozygous predicted deleterious variants in the <italic>PHIP</italic> gene with a common clinical phenotype of developmental delay, intellectual disability, anxiety, hypotonia, poor balance, obesity, and dysmorphic facial features.</p><p>The phenotype of our two patients is similar to a previously reported patient with a de novo heterozygous nonsense mutation in <italic>PHIP</italic>, p.Y1149* (c.3447T&gt;G), who has developmental delay, severe intellectual disability (IQ &lt; 50), obesity (weight &gt; +2 SD), and facial dysmorphisms (<xref rid="WEBSTERMCS001172C4" ref-type="bibr">de Ligt et al. 2012</xref>).</p><p>Nine patients with microdeletions spanning the 6q14.1 region including the <italic>PHIP</italic> gene have been reported with a similar phenotype including developmental delay, intellectual disability, hypotonia, and obesity (<xref rid="WEBSTERMCS001172C2" ref-type="bibr">Becker et al. 2012</xref>; <xref rid="WEBSTERMCS001172C24" ref-type="bibr">Wentzel et al. 2010</xref>). However, patients with microdeletions encompassing the <italic>PHIP</italic> gene have a number of additional clinical findings that do not overlap with the phenotype of our patients, probably because of the deletion of adjacent genes in 6q14. We suggest that the microdeletion data, our frameshift mutation, and the previously reported patient with a nonsense mutation support an autosomal dominant loss-of-function mechanism for disease caused by mutations in <italic>PHIP</italic>. <italic>PHIP</italic> is predicted to be sensitive to haploinsufficiency (<xref rid="WEBSTERMCS001172C10" ref-type="bibr">Huang et al. 2010</xref>).</p><p><italic>PHIP</italic> produces at least three proteins through alternative splicing: PHIP1 (also known as DCAF14), PHIP, and NDRP (<xref ref-type="fig" rid="WEBSTERMCS001172F2">Fig. 2</xref>; <xref rid="WEBSTERMCS001172C6" ref-type="bibr">Farhang-Fallah et al. 2000</xref>; <xref rid="WEBSTERMCS001172C12" ref-type="bibr">Kato et al. 2000</xref>; <xref rid="WEBSTERMCS001172C20" ref-type="bibr">Podcheko et al. 2007</xref>). Domains of these proteins include a Î²-propeller-forming WD40 repeat domain, nuclear localization signals, a pleckstrin homology domain-binding region, and bromodomains (<xref rid="WEBSTERMCS001172C6" ref-type="bibr">Farhang-Fallah et al. 2000</xref>; <xref rid="WEBSTERMCS001172C20" ref-type="bibr">Podcheko et al. 2007</xref>). Notably, PHIP1 is the only protein product disrupted by all three variants. The two predicted deleterious variants we report are in the PHIP1 and NDRP protein-coding region, and the mutation described by <xref rid="WEBSTERMCS001172C4" ref-type="bibr">de Ligt et al. (2012)</xref> falls in the PHIP1 and PHIP protein-coding region. It is possible that the phenotype observed in our patients is due to disruption of PHIP1 alone.</p><fig id="WEBSTERMCS001172F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>(<italic>A</italic>) Schematic representation of <italic>PHIP</italic> protein products and predicted deleterious variants. <italic>PHIP</italic> produces at least three proteins through alternative splicing: PHIP1 (also known as DCAF14), PHIP, and NDRP. (<italic>B</italic>) <italic>PHIP</italic> sequence conservation across species. Underlined letter in sequences aligns with the p.F17S variant.</p></caption><graphic xlink:href="WebsterMCS001172_F2"/></fig><p>PHIP1, also known as DCAF14 (DDB1- and CUL4-associated factor), is a member of the DCAF protein family (<xref rid="WEBSTERMCS001172C11" ref-type="bibr">Jin et al. 2006</xref>; <xref rid="WEBSTERMCS001172C15" ref-type="bibr">Lee and Zhou 2007</xref>). DCAFs act as substrate receptors for ubiquitin E3 ligases using a CUL4-DDB1 complex (<xref rid="WEBSTERMCS001172C9" ref-type="bibr">Higa et al. 2006</xref>; <xref rid="WEBSTERMCS001172C8" ref-type="bibr">Higa and Zhang 2007</xref>). The CUL4-DBB1 ubiquitin ligase binds to various substrate receptors to target specific proteins for proteolysis and is involved in a variety of regulatory pathways, including gene transcription, cell cycle, cell death, and embryonic development (<xref rid="WEBSTERMCS001172C8" ref-type="bibr">Higa and Zhang 2007</xref>; <xref rid="WEBSTERMCS001172C15" ref-type="bibr">Lee and Zhou 2007</xref>). The substrate(s) and protein targets of the CUL4-DDB1-PHIP1 complex are not yet known.</p><p>The role of PHIP1 as a substrate receptor for the CUL4-DDB1 complex may explain how the p.F17S variant causes protein dysfunction. At least seven DCAFs have Î±-helices close to the amino terminus that are important for DCAF-DDB1 binding (<xref rid="WEBSTERMCS001172C16" ref-type="bibr">Li et al. 2010</xref>). This binding motif, termed H-box, is thought to facilitate DCAF-DDB1 interaction in part through hydrophobic interactions (<xref rid="WEBSTERMCS001172C16" ref-type="bibr">Li et al. 2010</xref>). The amino-terminus Î±-helix of PHIP1, in which the missense variant is located, may function as an H-box (<xref ref-type="fig" rid="WEBSTERMCS001172F3">Fig. 3</xref>). The substitution of a hydrophobic amino acid, phenylalanine, for a hydrophilic amino acid, serine, could disrupt PHIP1-DDB1 binding.</p><fig id="WEBSTERMCS001172F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Depiction of the CUL4-DDB1 ubiquitin ligase complex and the role of the predicted PHIP1 H-box. Yellow lines indicate hydrophobic interactions between the PHIP1 H-box and DDB1. Ub, ubiquitin; E, ubiquitin-conjugating enzyme; R, RING finger protein. (Adapted from <xref rid="WEBSTERMCS001172C15" ref-type="bibr">Lee and Zhou 2007</xref>.)</p></caption><graphic xlink:href="WebsterMCS001172_F3"/></fig><p>CUL4, a member of the cullin-RING ubiquitin ligase family, is expressed in mammals as two paralogs, CUL4A and CUL4B (<xref rid="WEBSTERMCS001172C25" ref-type="bibr">Zhao and Sun 2012</xref>). <italic>CUL4B</italic> is encoded on the X Chromosome, and deficiency in males is associated with intellectual disability, seizures, aggressive outbursts, central obesity, muscle wasting, short stature, macrocephaly, and dysmorphic features including brachydactyly, macroglossia, pes cavus, and prominent upper lip (<xref rid="WEBSTERMCS001172C23" ref-type="bibr">Tarpey et al. 2007</xref>; <xref rid="WEBSTERMCS001172C25" ref-type="bibr">Zhao and Sun 2012</xref>). The phenotype of patients with <italic>CUL4B</italic> mutations overlaps with the phenotype of our patients. Because CUL4B and PHIP1 function in the same ubiquitin ligase pathway, the similarities support our suggestion that <italic>PHIP</italic> variants are causative of the phenotype in our patients.</p><p>PHIP1 is ubiquitously expressed in mice, with higher levels of expression in brain, pancreatic islet, and skeletal muscle cells (<xref rid="WEBSTERMCS001172C20" ref-type="bibr">Podcheko et al. 2007</xref>). The expression pattern is consistent with the neurologic and metabolic phenotypes in our patients. The obesity in these patients could be the result of disruption of PHIP1 effects on brain-mediated food intake and energetics. The insulin resistance observed could be secondary to obesity or mediated centrally. Through its pleckstrin homology domain-binding region, PHIP interacts with insulin receptor substrate 1 (IRS1) to propagate insulin signaling, leading to insulin-dependent mitogenesis and GLUT4 translocation to the plasma membrane because of cytoskeletal reorganization (<xref rid="WEBSTERMCS001172C7" ref-type="bibr">Farhang-Fallah et al. 2002</xref>). The expression pattern of <italic>Phip1</italic> in mice, the similar phenotype of our two patients, the previously reported patient with a <italic>PHIP</italic> mutation, and the overlapping phenotype of individuals with 6q14.1 microdeletions and <italic>CUL4B</italic> mutations collectively suggest that the mutation in <italic>PHIP</italic> is responsible for the phenotype observed in our patients and that the phenotype is probably caused by disruption of the ubiquitin ligase pathway due to loss of function of PHIP1.</p></sec><sec sec-type="methods" id="s4"><title>METHODS</title><sec id="s4a"><title>Whole-Exome Sequencing</title><p>Genomic DNA was extracted from whole blood of affected children and their parents. Exome sequencing was performed on exon targets captured using the Agilent SureSelect Human All Exon V4 (50 Mb) kit (Agilent Technologies). The sequencing methodology and variant interpretation protocol has been described previously (<xref rid="WEBSTERMCS001172C22" ref-type="bibr">Tanaka et al. 2015</xref>). Variants were confirmed by Sanger sequencing. The general assertion criteria for variant classification are publicly available on the GeneDx ClinVar submission page (<uri xlink:href="http://www.ncbi.nlm.nih.gov/clinvar/submitters/26957/">http://www.ncbi.nlm.nih.gov/clinvar/submitters/26957/</uri>).</p></sec></sec><sec id="s5"><title>ADDITIONAL INFORMATION</title><sec id="s5a"><title>Data Deposition and Access</title><p>The <italic>PHIP</italic> variants found in this study have been deposited in ClinVar (<uri xlink:href="http://www.ncbi.nlm.nih.gov/clinvar/">http://www.ncbi.nlm.nih.gov/clinvar/</uri>) under accession numbers SCV000282077 and SCV000282078. Raw WES data could not be deposited because of a lack of patient permission.</p></sec><sec id="s5b"><title>Ethics Statement</title><p>This study was approved by the Institutional Review Board of Columbia University. Consent to be part of this study was obtained from both families (verbal consent from the family of Patient 1 and written consent from the family of Patient 2).</p></sec><sec id="s5c"><title>Acknowledgments</title><p>We gratefully acknowledge the contributions of the patients and their families.</p></sec><sec id="s5d"><title>Author Contributions</title><p>E.W., M.T.C., N.A., and J.J. analyzed the data as well as drafted and critically reviewed the manuscript. S.D., S.N., M.R.B., and A.L. provided the clinical data and critically reviewed the manuscript. K.R. generated and analyzed the data and critically reviewed the manuscript. W.K.C. conceived of the study, analyzed the data, and drafted and critically reviewed the manuscript.</p></sec><sec id="s5e"><title>Funding</title><p>This work was supported in part by a grant from the Simons Foundation to W.K.C. and a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) T35 training grant (T35DK093430) to E.W.</p></sec><sec id="s5f"><title>Competing Interest Statement</title><p>M.T.C., K.R., and J.J. are employees of GeneDx. W.K.C. is a former employee of GeneDx.</p></sec></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>Supplemental Material</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_2_6_a001172__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="msword" xlink:href="supp_mcs.a001172_SuppTable1.docx"/>
</supplementary-material>
</sec>
</body>
  <back>
    <fn-group>
      <fn fn-type="supplementary-material">
        <p>[Supplemental material is available for this article.]</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="WEBSTERMCS001172C1">
        <mixed-citation publication-type="journal"><name><surname>Ardley</surname><given-names>HC</given-names></name>, <name><surname>Robinson</surname><given-names>PA</given-names></name>. <year>2004</year>
<article-title>The role of ubiquitin-protein ligases in neurodegenerative disease</article-title>. <source>Neurodegener Dis</source>
<volume>1</volume>: <fpage>71</fpage>â<lpage>87</lpage>.<pub-id pub-id-type="pmid">16908979</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C2">
        <mixed-citation publication-type="journal"><name><surname>Becker</surname><given-names>K</given-names></name>, <name><surname>Di Donato</surname><given-names>N</given-names></name>, <name><surname>Holder-Espinasse</surname><given-names>M</given-names></name>, <name><surname>Andrieux</surname><given-names>J</given-names></name>, <name><surname>Cuisset</surname><given-names>JM</given-names></name>, <name><surname>VallÃ©e</surname><given-names>L</given-names></name>, <name><surname>Plessis</surname><given-names>G</given-names></name>, <name><surname>Jean</surname><given-names>N</given-names></name>, <name><surname>Delobel</surname><given-names>B</given-names></name>, <name><surname>Thuresson</surname><given-names>AC</given-names></name>, <etal/>
<year>2012</year>
<article-title>De novo microdeletions of chromosome 6q14.1-q14.3 and 6q12.1-q14.1 in two patients with intellectual disabilityâfurther delineation of the 6q14 microdeletion syndrome and review of the literature</article-title>. <source>Eur J Med Genet</source>
<volume>55</volume>: <fpage>490</fpage>â<lpage>497</lpage>.<pub-id pub-id-type="pmid">22561202</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C3">
        <mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>Y</given-names></name>, <name><surname>Chan</surname><given-names>AP</given-names></name>. <year>2015</year>
<article-title>PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels</article-title>. <source>Bioinformatics</source>
<volume>31</volume>: <fpage>2745</fpage>â<lpage>2747</lpage>.<pub-id pub-id-type="pmid">25851949</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C4">
        <mixed-citation publication-type="journal"><name><surname>de Ligt</surname><given-names>J</given-names></name>, <name><surname>Willemsen</surname><given-names>MH</given-names></name>, <name><surname>van Bon</surname><given-names>BW</given-names></name>, <name><surname>Kleefstra</surname><given-names>T</given-names></name>, <name><surname>Yntema</surname><given-names>HG</given-names></name>, <name><surname>Kroes</surname><given-names>T</given-names></name>, <name><surname>Vulto-van Silfhout</surname><given-names>AT</given-names></name>, <name><surname>Koolen</surname><given-names>DA</given-names></name>, <name><surname>de Vries</surname><given-names>P</given-names></name>, <name><surname>Gilissen</surname><given-names>C</given-names></name>, <etal/>
<year>2012</year>
<article-title>Diagnostic exome sequencing in persons with severe intellectual disability</article-title>. <source>N Engl J Med</source>
<volume>367</volume>: <fpage>1921</fpage>â<lpage>1929</lpage>.<pub-id pub-id-type="pmid">23033978</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C5">
        <mixed-citation publication-type="journal"><collab>Exome Aggregation Consortium</collab>, <name><surname>Lek</surname><given-names>M</given-names></name>, <name><surname>Karczewski</surname><given-names>K</given-names></name>, <name><surname>Minikel</surname><given-names>E</given-names></name>, <name><surname>Samocha</surname><given-names>K</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <name><surname>O'Donnell-Luria</surname><given-names>A</given-names></name>, <name><surname>Ware</surname><given-names>J</given-names></name>, <name><surname>Hill</surname><given-names>A</given-names></name>, <etal/>
<year>2015</year>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source>bioRxiv</source>
<pub-id pub-id-type="doi">10.1101/030338</pub-id>.</mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C6">
        <mixed-citation publication-type="journal"><name><surname>Farhang-Fallah</surname><given-names>J</given-names></name>, <name><surname>Yin</surname><given-names>X</given-names></name>, <name><surname>Trentin</surname><given-names>G</given-names></name>, <name><surname>Cheng</surname><given-names>AM</given-names></name>, <name><surname>Rozakis-Adcock</surname><given-names>M</given-names></name>. <year>2000</year>
<article-title>Cloning and characterization of PHIP, a novel insulin receptor substrate-1 pleckstrin homology domain interacting protein</article-title>. <source>J Biol Chem</source>
<volume>275</volume>: <fpage>40492</fpage>â<lpage>40497</lpage>.<pub-id pub-id-type="pmid">11018022</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C7">
        <mixed-citation publication-type="journal"><name><surname>Farhang-Fallah</surname><given-names>J</given-names></name>, <name><surname>Randhawa</surname><given-names>VK</given-names></name>, <name><surname>Nimnual</surname><given-names>A</given-names></name>, <name><surname>Klip</surname><given-names>A</given-names></name>, <name><surname>Bar-Sagi</surname><given-names>D</given-names></name>, <name><surname>Rozakis-Adcock</surname><given-names>M</given-names></name>. <year>2002</year>
<article-title>The pleckstrin homology (PH) domain-interacting protein couples the insulin receptor substrate 1 PH domain to insulin signaling pathways leading to mitogenesis and GLUT4 translocation</article-title>. <source>Mol Cell Biol</source>
<volume>22</volume>: <fpage>7325</fpage>â<lpage>7336</lpage>.<pub-id pub-id-type="pmid">12242307</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C8">
        <mixed-citation publication-type="journal"><name><surname>Higa</surname><given-names>LA</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>. <year>2007</year>
<article-title>Stealing the spotlight: CUL4-DDB1 ubiquitin ligase docks WD40-repeat proteins to destroy</article-title>. <source>Cell Div</source>
<volume>2</volume>: <fpage>5</fpage>.<pub-id pub-id-type="pmid">17280619</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C9">
        <mixed-citation publication-type="journal"><name><surname>Higa</surname><given-names>LA</given-names></name>, <name><surname>Wu</surname><given-names>M</given-names></name>, <name><surname>Ye</surname><given-names>T</given-names></name>, <name><surname>Kobayashi</surname><given-names>R</given-names></name>, <name><surname>Sun</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>. <year>2006</year>
<article-title>CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation</article-title>. <source>Nat Cell Biol</source>
<volume>8</volume>: <fpage>1277</fpage>â<lpage>1283</lpage>.<pub-id pub-id-type="pmid">17041588</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C10">
        <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>N</given-names></name>, <name><surname>Insuk</surname><given-names>L</given-names></name>, <name><surname>Marcotte</surname><given-names>EM</given-names></name>, <name><surname>Hurles</surname><given-names>ME</given-names></name>. <year>2010</year>
<article-title>Characterising and predicting haploinsufficiency in the human genome</article-title>. <source>PLoS Genet</source>
<volume>6</volume>: <fpage>e1001154</fpage>.<pub-id pub-id-type="pmid">20976243</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C11">
        <mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>J</given-names></name>, <name><surname>Arias</surname><given-names>EE</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Harper</surname><given-names>JW</given-names></name>, <name><surname>Walter</surname><given-names>JC</given-names></name>. <year>2006</year>
<article-title>A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1</article-title>. <source>Mol Cell</source>
<volume>23</volume>: <fpage>709</fpage>â<lpage>721</lpage>.<pub-id pub-id-type="pmid">16949367</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C12">
        <mixed-citation publication-type="journal"><name><surname>Kato</surname><given-names>H</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Kiyama</surname><given-names>H</given-names></name>, <name><surname>Ikeda</surname><given-names>K</given-names></name>, <name><surname>Kimura</surname><given-names>N</given-names></name>, <name><surname>Nakashima</surname><given-names>K</given-names></name>, <name><surname>Taga</surname><given-names>T</given-names></name>. <year>2000</year>
<article-title>Identification of a novel WD repeat-containing gene predominantly expressed in developing and regenerating neurons</article-title>. <source>J Biochem</source>
<volume>128</volume>: <fpage>923</fpage>â<lpage>932</lpage>.<pub-id pub-id-type="pmid">11098134</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C13">
        <mixed-citation publication-type="journal"><name><surname>Kircher</surname><given-names>M</given-names></name>, <name><surname>Witten</surname><given-names>DM</given-names></name>, <name><surname>Jain</surname><given-names>P</given-names></name>, <name><surname>O'Roak</surname><given-names>BJ</given-names></name>, <name><surname>Cooper</surname><given-names>GM</given-names></name>, <name><surname>Shendure</surname><given-names>J</given-names></name>. <year>2014</year>
<article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source>Nat Genet</source>
<volume>46</volume>: <fpage>310</fpage>â<lpage>315</lpage>.<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C14">
        <mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>P</given-names></name>, <name><surname>Henikoff</surname><given-names>S</given-names></name>, <name><surname>Ng</surname><given-names>PC</given-names></name>. <year>2009</year>
<article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>. <source>Nat Protoc</source>
<volume>4</volume>: <fpage>1073</fpage>â<lpage>1081</lpage>.<pub-id pub-id-type="pmid">19561590</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C15">
        <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>P</given-names></name>. <year>2007</year>
<article-title>DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase</article-title>. <source>Mol Cell</source>
<volume>26</volume>: <fpage>775</fpage>â<lpage>780</lpage>.<pub-id pub-id-type="pmid">17588513</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C16">
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Robert</surname><given-names>EI</given-names></name>, <name><surname>van Breugel</surname><given-names>PC</given-names></name>, <name><surname>Strubin</surname><given-names>M</given-names></name>, <name><surname>Zheng</surname><given-names>N</given-names></name>. <year>2010</year>
<article-title>A promiscuous Î±-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery</article-title>. <source>Nat Struct Mol Biol</source>
<volume>17</volume>: <fpage>105</fpage>.<pub-id pub-id-type="pmid">19966799</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C17">
        <mixed-citation publication-type="journal"><name><surname>Lipkowitz</surname><given-names>S</given-names></name>, <name><surname>Weissman</surname><given-names>AM</given-names></name>. <year>2011</year>
<article-title>RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis</article-title>. <source>Nat Rev Cancer</source>
<volume>11</volume>: <fpage>629</fpage>â<lpage>643</lpage>.<pub-id pub-id-type="pmid">21863050</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C18">
        <mixed-citation publication-type="journal"><name><surname>Lohr</surname><given-names>NJ</given-names></name>, <name><surname>Molleston</surname><given-names>JP</given-names></name>, <name><surname>Strauss</surname><given-names>KA</given-names></name>, <name><surname>Torres-Martinez</surname><given-names>W</given-names></name>, <name><surname>Sherman</surname><given-names>EA</given-names></name>, <name><surname>Squires</surname><given-names>RH</given-names></name>, <name><surname>Rider</surname><given-names>NL</given-names></name>, <name><surname>Chikwava</surname><given-names>KR</given-names></name>, <name><surname>Cummings</surname><given-names>OW</given-names></name>, <name><surname>Morton</surname><given-names>DH</given-names></name>, <etal/>
<year>2010</year>
<article-title>Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease</article-title>. <source>Am J Hum Genet</source>
<volume>86</volume>: <fpage>447</fpage>â<lpage>453</lpage>.<pub-id pub-id-type="pmid">20170897</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C19">
        <mixed-citation publication-type="journal"><name><surname>Matentzoglu</surname><given-names>K</given-names></name>, <name><surname>Scheffner</surname><given-names>M</given-names></name>. <year>2008</year>
<article-title>Ubiquitin ligase E6-AP and its role in human disease</article-title>. <source>Biochem Soc Trans</source>
<volume>36</volume>: <fpage>797</fpage>â<lpage>801</lpage>.<pub-id pub-id-type="pmid">18793139</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C20">
        <mixed-citation publication-type="journal"><name><surname>Podcheko</surname><given-names>A</given-names></name>, <name><surname>Northcott</surname><given-names>P</given-names></name>, <name><surname>Bikopoulos</surname><given-names>G</given-names></name>, <name><surname>Lee</surname><given-names>A</given-names></name>, <name><surname>Bommareddi</surname><given-names>SR</given-names></name>, <name><surname>Kushner</surname><given-names>JA</given-names></name>, <name><surname>Farhang-Fallah</surname><given-names>J</given-names></name>, <name><surname>Rozakis-Adcock</surname><given-names>M</given-names></name>. <year>2007</year>
<article-title>Identification of a WD40 repeat-containing isoform of PHIP as a novel regulator of Î²-cell growth and survival</article-title>. <source>Mol Cell Biol</source>
<volume>27</volume>: <fpage>6484</fpage>â<lpage>6496</lpage>.<pub-id pub-id-type="pmid">17636024</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C21">
        <mixed-citation publication-type="journal"><name><surname>Schwarz</surname><given-names>JM</given-names></name>, <name><surname>Cooper</surname><given-names>DN</given-names></name>, <name><surname>Schuelke</surname><given-names>M</given-names></name>, <name><surname>Seelow</surname><given-names>D</given-names></name>. <year>2014</year>
<article-title>MutationTaster2: mutation prediction for the deep-sequencing age</article-title>. <source>Nat Methods</source>
<volume>11</volume>: <fpage>361</fpage>â<lpage>362</lpage>.<pub-id pub-id-type="pmid">24681721</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C22">
        <mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>AJ</given-names></name>, <name><surname>Cho</surname><given-names>MT</given-names></name>, <name><surname>Millan</surname><given-names>F</given-names></name>, <name><surname>Juusola</surname><given-names>J</given-names></name>, <name><surname>Retterer</surname><given-names>K</given-names></name>, <name><surname>Joshi</surname><given-names>C</given-names></name>, <name><surname>Niyazov</surname><given-names>D</given-names></name>, <name><surname>Garnica</surname><given-names>A</given-names></name>, <name><surname>Gratz</surname><given-names>E</given-names></name>, <name><surname>Deardorff</surname><given-names>M</given-names></name>, <etal/>
<year>2015</year>
<article-title>Mutations in SPATA5 are associated with microcephaly, intellectual disability, seizures, and hearing loss</article-title>. <source>Am J Hum Genet</source>
<volume>97</volume>: <fpage>457</fpage>â<lpage>464</lpage>.<pub-id pub-id-type="pmid">26299366</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C23">
        <mixed-citation publication-type="journal"><name><surname>Tarpey</surname><given-names>PS</given-names></name>, <name><surname>Raymond</surname><given-names>FL</given-names></name>, <name><surname>O'Meara</surname><given-names>S</given-names></name>, <name><surname>Edkins</surname><given-names>S</given-names></name>, <name><surname>Teague</surname><given-names>J</given-names></name>, <name><surname>Butler</surname><given-names>A</given-names></name>, <name><surname>Dicks</surname><given-names>E</given-names></name>, <name><surname>Stevens</surname><given-names>C</given-names></name>, <name><surname>Tofts</surname><given-names>C</given-names></name>, <name><surname>Avis</surname><given-names>T</given-names></name>, <etal/>
<year>2007</year>
<article-title>Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor</article-title>. <source>Am J Hum Genet</source>
<volume>80</volume>: <fpage>345</fpage>â<lpage>352</lpage>.<pub-id pub-id-type="pmid">17236139</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C24">
        <mixed-citation publication-type="journal"><name><surname>Wentzel</surname><given-names>C</given-names></name>, <name><surname>Lynch</surname><given-names>SA</given-names></name>, <name><surname>Stattin</surname><given-names>EL</given-names></name>, <name><surname>Sharkey</surname><given-names>FH</given-names></name>, <name><surname>AnnerÃ©n</surname><given-names>G</given-names></name>, <name><surname>Thuresson</surname><given-names>AC</given-names></name>. <year>2010</year>
<article-title>Interstitial deletions at 6q14.1-q15 associated with obesity, developmental delay and a distinct clinical phenotype</article-title>. <source>Mol Syndromol</source>
<volume>1</volume>: <fpage>75</fpage>â<lpage>81</lpage>.<pub-id pub-id-type="pmid">21045960</pub-id></mixed-citation>
      </ref>
      <ref id="WEBSTERMCS001172C25">
        <mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>. <year>2012</year>
<article-title>CUL4B ubiquitin ligase in mouse development: a model for human X-linked mental retardation syndrome?</article-title>
<source>Cell Res</source>
<volume>22</volume>: <fpage>1224</fpage>â<lpage>1226</lpage>.<pub-id pub-id-type="pmid">22584258</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>